Skip to main content
. 2015 Jun 8;309(3):H523–H528. doi: 10.1152/ajpheart.00267.2015

Table 2.

Blood markers pre- and postketorolac

PAD Patients
Healthy Subjects
Preketorolac Postketorolac Preketorolac Postketorolac
Thromboxane B2, pg/ml 120 ± 28† 84 ± 4 714 ± 32 232 ± 3*
6-Keto-PGF1α, pg/ml 88 ± 8† 87 ± 7 137 ± 88 22 ± 6*

Values are means ± SE; n = 7 PAD patients and 7 healthy control subjects.

*

Difference between preketorolac and postketorolac in healthy subjects; †difference between groups at the specific time point (P < 0.05).